NITTA; Hiro

Patent Applications and Registrations

Patent applications and USPTO patent grants for NITTA; Hiro.The latest application filed is for "her2 heterogeneity as a biomarker in cancer".

Company Profile

4.6.19

NITTA; Hiro - Tucson AZ
Nitta; Hiro - Oro Valley AZ US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Her2 Heterogeneity As A Biomarker In Cancer App 20210071270 - MURILLO; Adrian E. ; et al.	2021-03-11
Multiplex Her2 And Estrogen Receptor Co-staining Assays For Detecting Tumor Heterogeneity App 20210011023 - NITTA; Hiro ; et al.	2021-01-14
Method Of Identifying Treatment Responsive Non-small Cell Lung Cancer Using Anaplastic Lymphoma Kinase (alk) As A Marker App 20200225237 - Barnes; Michael ; et al.	2020-07-16
Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (ALK) as a marker Grant 10,620,207 - Grogan , et al.	2020-04-14
Multiplex Assay For Improved Scoring Of Tumor Tissues Stained For Pd-l1 App 20180031567 - Dennis; Eslie ; et al.	2018-02-01
MULTIPLEX TP53/CEN17/B CELL GENE-PROTEIN CO-DETECTION ASSAY AND UNIQUELY SPECIFIC PROBES FOR 19q12, INSR, ATM, DLEU2, TP53, AND 13q12 App 20170212122 - Alexander; Nelson R. ; et al.	2017-07-27
Method Of Identifying Treatment Responsive Non-small Cell Lung Cancer Using Anaplastic Lymphoma Kinase (alk) As A Marker App 20170205416 - Grogan; Thomas ; et al.	2017-07-20
Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (ALK) as a marker Grant 9,651,555 - Grogan , et al. May 16, 2	2017-05-16
Significance Of Intratumoral Her2 Heterogeniety In Breast Cancer And Uses Therefore App 20170082627 - Dennis; Eslie ; et al.	2017-03-23
Method of analyzing chromosomal inversions Grant 9,562,259 - Nitta , et al. February 7, 2	2017-02-07
Multiplex Her2 And Estrogen Receptor Co-staining Assays For Detecting Tumor Heterogeneity App 20170023579 - Nitta; Hiro ; et al.	2017-01-26
Simultaneous Detection Of Mutational Status And Gene Copy Number App 20160130666 - SINGH; SHALINI ; et al.	2016-05-12
Multiplex Assay For Improved Scoring Of Tumor Tissues Stained For Pd-l1 App 20150346210 - Nitta; Hiro ; et al.	2015-12-03
Method of Identifying Treatment Responsive Non-Small Cell Lung Cancer Using Anaplastic Lymphoma Kinase (ALK) as a Marker App 20150346206 - GROGAN; Thomas ; et al.	2015-12-03
Substrates for chromogenic detection and methods of use in detection assays and kits Grant 9,127,028 - Kelly , et al. September 8, 2	2015-09-08
Method For Chromogenic Detection Of Two Or More Target Molecules In A Single Sample App 20130273540 - Gniewek; Richard ; et al.	2013-10-17
Substrates For Chromogenic Detection And Methods Of Use In Detection Assays And Kits App 20130115593 - Kelly; Brian Daniel ; et al.	2013-05-09
Two-color Chromogenic In Situ Hybridization App 20130034853 - Kelly; Brian ; et al.	2013-02-07
Simultaneous Detection Of Mutational Status And Gene Copy Number App 20120264127 - Singh; Shalini ; et al.	2012-10-18
Method Of Analyzing Chromosomal Translocations And A System Therefore App 20120237930 - Nitta; Hiro ; et al.	2012-09-20
Low temperature deparaffinization App 20060252025 - Nitta; Hiro ; et al.	2006-11-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.